I do point out that there were some improvements in plaque reduction in the secondary endpoints in ILLUMINATE
I would suggest that this should worry a CETP inhibitor fan - that it causes more deaths while having some positive effect on atheroma volume. It means that inhibition of CETP is making the remaining atheroma more rupture prone.